Clinical pharmacology of 2,5′-diaziridinyl-3,6-biscarboethoxyamino-1,4-benzoquinone (AZQ)
作者： Katherine Lu , Niramol Savaraj , Boh Seng Yap , Agop Y. Bedikian , Lynn Feun
DOI: 10.1016/0277-5379(83)90175-X
关键词: Drug administration 、 Clinical pharmacology 、 Pharmacology 、 1,4-Benzoquinone 、 Urine 、 Volume of distribution 、 Cerebrospinal fluid 、 Antitumor activity 、 Urinary excretion 、 Chemistry 、 Oncology
摘要: 2,5′-Diaziridinyl-3,6-biscarboethoxyamino-1,4-benzoquinone (AZQ) is an alkylating compound which has exhibited a broad spectrum of antitumor activity against a variety of …
elsevier.com
sci-hub.se 参考文章(3)
RobertS. Benjamin, TiLi Loo, Niramol Savaraj, Katherine Lu, LynnG. Feun, MilamE. Leavens, David Stewart, MichaelA. Burgess, Intracerebral penetration and tissue distribution of 2,5-diaziridinyl 3,6-bis(carboethoxyamino) 1,4-benzoquinone (AZQ, NSC-182986) Journal of Neuro-oncology. ,vol. 1, pp. 15- 19 ,(1983) , 10.1007/BF00153636
John S. Driscoll, Leo Dudeck, George Congleton, Ruth I. Geran, Potential CNS Antitumor Agents VI: Aziridinylbenzoquinones III Journal of Pharmaceutical Sciences. ,vol. 68, pp. 185- 188 ,(1979) , 10.1002/JPS.2600680217
R R Levine, E W Pelikan, Mechanisms of Drug Absorption and Excretion Annual Review of Pharmacology. ,vol. 4, pp. 69- 84 ,(1964) , 10.1146/ANNUREV.PA.04.040164.000441